Dynorphin A activates bradykinin receptors to maintain neuropathic pain
by
Lai J, Luo MC, Chen Q, Ma S, Gardell LR, Ossipov MH, Porreca F.
Department of Pharmacology, University of Arizona Health Sciences Center,
1501 N. Campbell Ave., Tucson, Arizona 85724, USA.
Nat Neurosci. 2006 Nov 19;

ABSTRACT

Dynorphin A is an endogenous opioid peptide that produces non-opioid receptor-mediated neural excitation. Here we demonstrate that dynorphin induces calcium influx via voltage-sensitive calcium channels in sensory neurons by activating bradykinin receptors. This action of dynorphin at bradykinin receptors is distinct from the primary signaling pathway activated by bradykinin and underlies the hyperalgesia produced by pharmacological administration of dynorphin by the spinal route in rats and mice. Blockade of spinal B1 or B2 receptor also reverses persistent neuropathic pain but only when there is sustained elevation of endogenous spinal dynorphin, which is required for maintenance of neuropathic pain. These data reveal a mechanism for endogenous dynorphin to promote pain through its agonist action at bradykinin receptors and suggest new avenues for therapeutic intervention.

JDTic
Dynorphin and depression
Dynorphin, dopamine and CART
Kappa receptors, dopamine d3, and cocaine
Dynorphin: Nature's own antidote to cocaine?
Pro-pain actions of dynorphin via bradykinin receptors

Refs
and further reading

HOME
HedWeb
Nootropics
cocaine.wiki
Future Opioids
BLTC Research
MDMA/Ecstasy
Superhapiness?
Utopian Surgery?
The Abolitionist Project
The Hedonistic Imperative
The Reproductive Revolution
Critique of Huxley's Brave New World

The Good Drug Guide
The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family